An eye-opening article in EP Lab Digest finds that (EP) labs are missing out on an estimated $500 million in savings each year due to underutilization of reprocessing in atrial fibrillation (AFib) and other catheter ablation procedures. Hospitals urgently need to find cost savings like boosting reprocessing programs to recover from the economic devastation of COVID-19.

“In the current economic climate, single-use device reprocessing must be part of the supply chain strategy, and it’s our hope that this new economic analysis and whitepaper will give hospital administrators the information they need to ensure their reprocessing programs are leveraged for maximum savings.”

Congrats to our member Innovative Health.